Fight COVID with mAbs

Monoclonal Antibody Treatment for COVID-19
At Home & No-Cost

Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization.

Enter your zip code to see if you qualify.

Protect Yourself

Authorized by the FDA

Free and Easy at Home

Free at-home monoclonal antibody treatment for those who have tested positive for COVID-19. See if you qualify by entering your zip code.

Contact Info

Quick Links

Do you Qualify?

Enter your zip code to see if you qualify.

Please note that mAbs At Home provides monoclonal antibody treatments utilizing several types of FDA authorized monoclonals. Circulating SARS-CoV-2 viral variants, including Omicron, may be associated with resistance to monoclonal antibodies. The frequency of the Omicron variant is increasing throughout the U.S. Data shows that it is unlikely that Eli Lilly’s bamlanivimab and etesevimab or Regenron’s REGEN-COV will retain activity against this variant. GSK’s Sotrovimab appears to retain activity against the Omicron variant. Mabs At Home is currently following guidance by reserving GSK’s Sotrovimab for only the highest-risk patients.

Website by My Custom Software

English

Fight COVID with mAbs

Monoclonal Antibody Treatment for COVID-19 At Home & No-Cost

Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization.

Enter your zip code to see if you qualify.

Protect Yourself

Authorized by the FDA

Free and Easy at Home

Contact Info

Quick Links

Do you Qualify?

Enter your zip code to see if you qualify.

Monoclonal Antibody Treatment for COVID-19
At Home & No-Cost